Market Tracker

04/17 6:05pm ET

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

4.52
Data as of Apr 17
 +0.02 / +0.44%
Today’s Change
2.05
Today|||52-Week Range
7.09
-15.21%
Year-to-Date

Today’s Trading

Previous close4.50
Today’s open4.50
Day’s range4.41 - 4.65
Volume725,593
Average volume (3 months)1,435,319
Market cap$504.9M
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)-5.32%
Earnings growth (this year)+11.99%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)-2.32%
P/E ratioNM
Price/Sales11.04
Price/Book--

Competitors

 Today’s
change
Today’s
% change
INFIInfinity Pharmaceuti...-0.45-4.25%
VVUSVIVUS Inc+0.11+2.10%
RPTPRaptor Pharmaceutica...-0.27-3.18%
ARRYArray Biopharma Inc-0.05-1.30%
Data as of 3:59pm ET, 04/17/2014

Financials

Next reporting dateMay 13, 2014
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$47.8M
Annual profit (last year)-$130.9M
Net profit margin-273.98%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Senior Vice President-
Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts